SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
| Imodium Plus Caplets | 125,2 mg,mg | Tablet · Oral use | 12 Blister | SAR 25.70 | NCE · OTC | MCNEIL PRODUCTS LIMITED | Valid |
US FDA United States — FDA approvals (Drugs@FDA)
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
| IMODIUM COMPLETE | 02245185 | 125 MG; 2 MG | TABLET · ORAL | KENVUE CANADA INC. |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
| NHS Drug Tariff | Loperamide 2mg / Simeticone 125mg tablets | £3.39 | 6 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Loperamide 2mg / Simeticone 125mg tablets | £5.94 | 12 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.